This report explores the fusion of AI and biotechnology—showing how machine learning drives breakthroughs in protein folding, gene editing, and drug discovery, while bio-inspired algorithms inform next-gen neural networks. It profiles leading platforms (from AlphaFold to lab-automation AI), examines real-world successes in precision medicine and synthetic biology, and tackles the ethical, regulatory, and safety challenges of “living” AI systems. The report concludes with strategic recommendations for researchers, investors, and policymakers to responsibly accelerate this convergent revolution.